Results and cost analysis of Amplatzer® Ductal Occluder-ii, Nit Occlud® Lê Coil, and Konar-MF® ventricular septal defect occluder for percutaneous ventricular septal defect closure

Eka Gunawijaya; Ni Putu Veny Kartika Yantie; Anlidya Permatasari Gunawijaya

doi:10.15562/bmj.v12i1.3487

Results and cost analysis of Amplatzer® Ductal Occluder-ii, Nit Occlud® Lê Coil, and Konar-MF® ventricular septal defect occluder for percutaneous ventricular septal defect closure

Eka Gunawijaya ,

Ni Putu Veny Kartika Yantie ,

Anlidya Permatasari Gunawijaya ,

pdf |
DOI: https://doi.org/10.15562/bmj.v12i1.3487 |
Published: 2023-03-30

Abstract

Background: A number of devices have been used for percutaneous closure of ventricular septal defect (VSD) in this era of Jaminan Kesehatan Nasional. The aim of this study is to describe the differences in results and cost analysis of various devices used for percutaneous closure of VSD.

Patients and methods: This retrospective study was done in 88 patients underwent transcatheter VSD closure between May 2015-April 2019 at Sanglah Hospital Indonesia (regional 2, medical service level 3). Three types of devices were compared: Amplatzer^® Ductal Occluder-II (ADO-II^®), Nit Occlud^® Lê Coil, and KONAR-MF^® VSD Occluder (MFO^®). Total cost and hospital earnings from Indonesia Case Based Groups (INA-CBG’s), procedure outcomes, and complications were recorded. Statistical analysis was done using Kruskal-Wallis test and Mann-Whitney test.

Results: Successful deployment of ADO-II^® Nit Occlud, ^® Lê Coil, and MFO^® were 33, 32, and 21 cases respectively. Procedure and fluoroscopy time were shorter in ADO-II^® compared to other groups (p=0.001 and 0.003). Complication rate was equally similar in all groups. Real cost was higher in Nit Occlud^® Lê Coil compared to other groups. Negative hospital earnings was smaller in ADO-II^® and MFO^® groups than Nit Occlud^® Lê Coil group (median -1,633,850 vs -14,006,600 vs -1,247,900 respectively), adjustment for length of stay found similar result. Adjustment by admission class found no difference of hospital earnings.

Conclusion: The ADO-II^® and MFO^® have the smallest cost. Considering the cost-effectiveness and feasibility, ADO-II^® can be chosen in small defects (<6 mm), meanwhile MFO^® in larger defects. All devices described have equal success rate and complications.

References

Chungsomprasong P, Durongpisitkul K, Vijarnsorn C, Soongswang J, Le TP. The results of transcatheter closure of VSD using Amplatzer® device and Nit Occlud® Lê Coil. Catheter Cardiovasc Interv. 2011;78(7):1032-40.
Nguyen HL, Phan QT, Dinh LH, Tran HB, Won H, Thottian JJ, et al. Nit-Occlud Lê VSD coil versus Duct Occluders for percutaneous perimembranous ventricular septal defect closure. Congenit Heart Dis. 2018 ;13(4):584-93.
Haas NA, Kock L, Bertram H, Boekenkamp R, De Wolf D, Ditkivskyy I, et al. Interventional VSD-closure with the Nit-Occlud® Lê VSD-Coil in 110 patients: early and midterm results of the EUREVECO-registry. Pediatr Cardiol. 2017;38(2):215-27.
Kuswiyanto RB, Gunawijaya E, Rahman MA. Experience of perimembranous VSD closure with Multi Functional Occluder in Indonesia: initial report. CSI Asia Pacific;2017 Mar 2-4; Bangkok, Thailand.
KONAR-MF® VSD Occluder [Internet]. Shenzhen: Lifetech Products; 2019 [cited 2019 December 1]. Available from: http://www.lifetechmed.com/en/product/p1/konar-mf%E2%84%A2%20vsd%20occluder/index.aspx.
Kemenkes. Peraturan Menteri Kesehatan Republik Indonesia Nomor 76 tahun 2016 Tentang Pedoman Indonesian Case Base Groups (INA-CBG) Dalam Pelaksanaan Jaminan Kesehatan Nasional, 2016.
Info Badan Penyelenggara Jaminan Sosial Kesehatan [Internet]. Jakarta: Badan Penyelenggara Jaminan Sosial Kesehatan; 2019 [cited 2019 April 1]. Available from: https://bpjs-kesehatan.go.id/bpjs/.
Borges F. Percutaneous transcatheter closure of perimembranous ventricular septal defects in one working group: long-term follow up. J Pediatr Neonatal Care. 2016;5(1):1-9.
Polat TB, Türkmen E. Transcatheter closure of ventricular septal defects using the Amplatzer Duct Occluder II device: a single-center experience. Postepy Kardiol Interwencyjnej. 2016;12(4):340-7.
Rodriguez FB, Sparano A, Robles Y, Urbano E, Hermanni M, Garcia C. Transcatheter membranous ventricular septal defect closure, with Nit-Occlud PFM device in one working group, long-term follow up. JOCCT. 2016;1(4):1-6.
Durongpisitkul K, Chungsomprasong P, Panjasamarnwong P, Darunaitorn S, Chanthong P, Vijarnsorn C, et al. Intermediate-term follow-up results of transcatheter closure of ventricular septal defect using Amplatzer® Device versus Nit-Occlud® Lê VSD Coil System. Southeast Asian J Trop Med Public Health. 2017;48(Suppl.2):49-64.
Cinteză EE, Butera G. Complex ventricular septal defects: update on percutaneous closure. Rom J Morphol Embryol. 2016;57(4):1195-1205.
Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, et al. Transcatheter closure of perimembranous VSD using the Amplatzer membranous VSD occluder. Catheter Cardiovasc Interv. 2006;68:620-8.
Ewert P, Kretschmar O, Peters B, Abdul-Khaliq H, Nagdyman N, Schulze-Neick I, et al. Transcatheter closure of congenital septal defects. Z Kardiol. 2004;93:147-55.
Balzer D. Current status of percutaneous closure of ventricular septal defects. Pediatr Therapeut. 2012;2:1-4.
Tai S, Tang L, Zhu Z, Fang Z, Hu X, Tang J, et al. Embolisation of perimembranous ventricular septal defect occluder and transcatheter retrieval. Heart Lung Circ. 2014;23(10):951-6.
Butera G, Carminati M, Chessa M, Piazza L, Micheletti A, Negura DG, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007;50:1189-95.
Yang L, Tai BC, Khin LW, Quek SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Interv Cardiol. 2014;27(3):260-72.
Liu S, Chen F, Ding X, Zhao Z, Ke W, Yan Y, et al. Comparison of results and economic analysis of surgical and transcatheter closure of perimembranous ventricular septal defect. Eur J Cardiothorac Surg. 2012;42:157-62.
Satriani L, Audrey, Yanuarso PB, Djer MM. Perbandingan luaran dan biaya penutupan defek septum ventrikel perimembran secara transkateter dan pembedahan. Sari Pediatri. 2015;17(1):9-16.